QLG1080

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLG1080, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer [Phase 3]